At close: December 20 at 4:00:03 PM EST
After hours: December 20 at 4:11:44 PM EST
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CARRUTHERS ROBERT MICHAEL Chief Financial Officer | Conversion of Exercise of derivative security | Oct 11, 2024 | 76,904 |
| DERAKHSHAN BEHRAD Officer | Sale | Sep 20, 2024 | 15,121 |
| DONOVAN JOANNE M Officer | Sale | Sep 20, 2024 | 14,538 |
| FOX JONATHAN C Director | Purchase | Dec 26, 2023 | 10,857 |
| KOCH KEVIN Chief Executive Officer | Sale | May 2, 2024 | 353,262 |
| MOORE JOHN R General Counsel | Sale | Sep 23, 2024 | 3,252 |
| ORBIMED ADVISORS, L.L.C. Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 23, 2024 | -- |
| RUSSELL ALAN J Officer and Director | Sale | Sep 20, 2024 | 12,719 |
| THOMPSON PETER A Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Jan 23, 2024 | -- |
Related Tickers
VRDN Viridian Therapeutics, Inc.
19.03
+1.60%
CRVS Corvus Pharmaceuticals, Inc.
4.9900
-1.96%
LRMR Larimar Therapeutics, Inc.
4.0100
+0.75%
BMEA Biomea Fusion, Inc.
4.2300
+3.68%
JANX Janux Therapeutics, Inc.
56.83
+0.14%
BHVN Biohaven Ltd.
36.26
+2.60%
MESO Mesoblast Limited
14.63
-12.71%
CYTK Cytokinetics, Incorporated
48.87
+4.56%
CNTA Centessa Pharmaceuticals plc
17.16
-2.22%
AGIO Agios Pharmaceuticals, Inc.
35.42
-1.09%